Elixinol Wellness Limited (ASX: EXL / OTC: ELLXF) – Ramping Up Revenue While Slashing Costs
Highlights In 2022, revenue fell 24% YoY to $7.1M, but beat our estimate by 8%. Revenue declined...
Read MoreHighlights In 2022, revenue fell 24% YoY to $7.1M, but beat our estimate by 8%. Revenue declined...
Read MoreHighlights This company develops and sells hemp-derived CBD nutraceutical, cosmetic, and food...
Read MoreHighlights We believe the project has resource expansion potential as Andover is one of several...
Read MoreHighlights Total resources of the Costa Fuego copper-gold project in Chile increased 17% to 8.3...
Read More